BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.80
-0.56 (-0.72%)
At close: Nov 17, 2026, 4:00 PM EST
76.76
-0.04 (-0.05%)
After-hours: Nov 17, 2026, 5:52 PM EST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Product Revenue
802.40M362.37M2.88M
License and Services Revenue
92.42M128.32M218.85M
Royalty Revenue
50.72M11.39M169.00K
Revenue (Total)
945.54M502.08M221.90M

Key Performance Indicators

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
U.S. - Geographic Revenue Distribution
72.20%6.00%
Europe, Middle East, and Africa (EMEA) - Geographic Revenue Distribution
25.30%59.50%
Asia-Pacific (APAC) - Geographic Revenue Distribution
2.50%34.50%